Asahi Kasei Corp (3407)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Asahi Kasei Corp (3407) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013486
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Asahi Kasei Corp (Asahi Kasei), formerly Asahi Chemical Industry Co. Ltd., manufactures, processes, and sells chemical products. It is a holding company of Asahi Kasei Group. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation panels, foundation systems, contact lenses, medical devices and electronic products. These products find application in the fields of chemicals and fibers, electronics, healthcare and construction. Asahi Kasei markets its products under various brand names such as Hebel Haus, Pimel, Elcitonin, Hebel Maison, Planova, Eazet, Neoma, Sunfort and Hipore through its subsidiaries. The company has operations presence in various countries including the UK, Belgium, Thailand, France, Germany, the US, Japan, Italy, Spain, Taiwan, Indonesia and Korea. Asahi Kasei is headquartered in Chiyoda-ku, Tokyo, Japan.

Asahi Kasei Corp (3407) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asahi Kasei Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Asahi Kasei Corp, Medical Devices Deals, 2011 to YTD 2017 9
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Xeris Pharma Raises Additional USD30 Million in Series C Financing 12
Advanced Circulatory Systems Raises US$2 Million In Financing 14
Partnerships 15
Evotec Enters into Agreement with Asahi Kasei Pharma 15
Orion Enters into Agreement with Asahi Kasei Pharma 16
PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 17
SPI Pharma Enters into Co-Marketing Agreement with Asahi Kasei Chemicals 18
RaQualia Pharma Enters Into Research Agreement With Asahi Kasei Pharma 19
Vernalis Enters Into Drug Discovery Agreement With Asahi Kasei 20
Hisamitsu Pharma Enters Into Co-Marketing Agreement With Asahi Kasei Pharma For HOB-294 21
Licensing Agreements 22
Asahi Kasei Enters into Licensing Agreement with Bone Therapeutics 22
Asahi Kasei Pharma Enters into Licensing Agreement with Array BioPharma 23
Basilea Pharma Enters into Licensing Agreement with Asahi Kasei Pharma 24
Asahi Kasei Pharma Enters into License Agreement with Dong-A ST 25
Auxilium Pharma Enters Into Licensing Agreement With Asahi Kasei For XIAFLEX 26
Equity Offering 28
tella Completes Private Placement Of Shares For US$3.9 Million 28
Acquisition 29
Asahi Kasei Pharma Acquires Remaining Stake In Artisan Pharma 29
Asahi Kasei Corp – Key Competitors 31
Asahi Kasei Corp – Key Employees 32
Asahi Kasei Corp – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Joint Venture 36
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asahi Kasei Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asahi Kasei Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Asahi Kasei Corp, Medical Devices Deals, 2011 to YTD 2017 9
Asahi Kasei Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Xeris Pharma Raises Additional USD30 Million in Series C Financing 12
Advanced Circulatory Systems Raises US$2 Million In Financing 14
Evotec Enters into Agreement with Asahi Kasei Pharma 15
Orion Enters into Agreement with Asahi Kasei Pharma 16
PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 17
SPI Pharma Enters into Co-Marketing Agreement with Asahi Kasei Chemicals 18
RaQualia Pharma Enters Into Research Agreement With Asahi Kasei Pharma 19
Vernalis Enters Into Drug Discovery Agreement With Asahi Kasei 20
Hisamitsu Pharma Enters Into Co-Marketing Agreement With Asahi Kasei Pharma For HOB-294 21
Asahi Kasei Enters into Licensing Agreement with Bone Therapeutics 22
Asahi Kasei Pharma Enters into Licensing Agreement with Array BioPharma 23
Basilea Pharma Enters into Licensing Agreement with Asahi Kasei Pharma 24
Asahi Kasei Pharma Enters into License Agreement with Dong-A ST 25
Auxilium Pharma Enters Into Licensing Agreement With Asahi Kasei For XIAFLEX 26
tella Completes Private Placement Of Shares For US$3.9 Million 28
Asahi Kasei Pharma Acquires Remaining Stake In Artisan Pharma 29
Asahi Kasei Corp, Key Competitors 31
Asahi Kasei Corp, Key Employees 32
Asahi Kasei Corp, Other Locations 34
Asahi Kasei Corp, Subsidiaries 34
Asahi Kasei Corp, Joint Venture 36

★海外企業調査レポート[Asahi Kasei Corp (3407)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wenzel Downhole Tools Ltd:企業の戦略的SWOT分析
    Wenzel Downhole Tools Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Korea Midland Power Co Ltd:企業の戦略的SWOT分析
    Korea Midland Power Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Constant Contact, Inc.:企業の戦略・SWOT・財務分析
    Constant Contact, Inc. - Strategy, SWOT and Corporate Finance Report Summary Constant Contact, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bank Sinopac
    Bank Sinopac - Strategy, SWOT and Corporate Finance Report Summary Bank Sinopac - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Alexza Pharmaceuticals Inc:企業の戦略的SWOT分析
    Alexza Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • ConAgra Brands Inc:企業のM&A・事業提携・投資動向
    ConAgra Brands Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ConAgra Brands Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • CS Wind Corp (112610):企業の財務・戦略的SWOT分析
    Summary CS Wind Corp (CS Wind) formerly Choong San Corp, is a global wind tower company that manufactures and distributes aluminum platforms used for wind power generation towers. The company’s products include transition piece, wind tower, tower internal parts, oil and gas pipes, and plant equipmen …
  • Energy XXI Gulf Coast Inc (EXXIQ):企業の財務・戦略的SWOT分析
    Summary Energy XXI Gulf Coast Inc (Energy XXI) is an oil and gas company that explores and develops oil and natural gas assets. The company’s projects include West Delta, South Timbalier, South Pass, Main Pass, and Ship Shoal. Its West Delta property is located 28 miles offshore of Grand Isle, Louis …
  • Evolution Petroleum Corp (EPM):石油・ガス:M&Aディール及び事業提携情報
    Summary Evolution Petroleum Corp (EPC), a subsidiary of Esrey Resources Ltd, is an oil and gas company that acquires and explores crude oil and natural gas properties. The company explores for oil, liquefied gas, natural gas, and gas reserves in Delhi field CO2-EOR project. It offers GARP or gas ass …
  • Indowind Energy Ltd (INDOWIND):電力:M&Aディール及び事業提携情報
    Summary Indowind Energy Ltd (Indowind Energy) is a renewable energy company that develops and manages wind farms and wind assets, and generates green power for sale to utilities and corporate. The company offers project management, wind asset management, and value addition services. It also provides …
  • PerkinElmer Inc (PKI):医療機器:M&Aディール及び事業提携情報
    Summary PerkinElmer Inc (PerkinElmer) is a provider of detection and imaging technologies, consumables, informatics solutions, accessories and services to diagnostics, research, food, laboratory services, environmental, and industrial markets. The company’s major products include cytogenetics reagen …
  • Hansen Medical Inc:企業の製品パイプライン分析2018
    Summary Hansen Medical Inc (Hansen Medical), formerly Autocath Inc, a subsidiary of Auris Health Inc, is a medical device company that develops, manufactures and markets magellan robotic system for peripheral vascular intervention. The company’s products comprise robotic system, robotic catheters, s …
  • Nielsen Holdings PLC:企業のM&A・事業提携・投資動向
    Nielsen Holdings PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nielsen Holdings PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Promimic AB:医療機器:M&Aディール及び事業提携情報
    Summary Promimic AB (Promimic) is a biomaterial company that develops and markets nano-thin surface modifications for all implant materials and geometries. The company offers thin HA surface modification for orthopedic and dental implants, which improves osseointegration and bone healing around inte …
  • Agilysys Inc (AGYS):企業の財務・戦略的SWOT分析
    Agilysys Inc (AGYS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Midwest Energy Cooperative:企業の戦略的SWOT分析
    Midwest Energy Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • RISE Life Science Corp:企業のM&A・事業提携・投資動向
    RISE Life Science Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RISE Life Science Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Mincor Resources NL:企業の戦略・SWOT・財務情報
    Mincor Resources NL - Strategy, SWOT and Corporate Finance Report Summary Mincor Resources NL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • UniCredit S.p.A:企業のM&A・事業提携・投資動向
    UniCredit S.p.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UniCredit S.p.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Pacific Gas and Electric Co:企業の戦略的SWOT分析
    Pacific Gas and Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆